John Ormiston1,2,6*, MBChB; Pascal Motreff3, MD; Olivier Darremont4, MD; Bruce Webber2, MHSc; Patrice Guerin5, MD; Mark Webster2,6, MBChB
1. Mercy Angiography, Auckland, New Zealand; 2. University of Auckland School of Medicine, Auckland, New Zealand; 3. University Hospital, Clermont-Ferrand, France; 4. Clinique Saint-Augustin, Bordeaux, France; 5. L’Université de Nantes, Nantes, France; 6.
Bioresorbable scaffolds (BRS) in bifurcations have all of the potential advantages of BRS in non-bifurcating lesions and, in addition, the absorption of side branch (SB) ostial struts may at least partially release the branch